IKT INHIBIKASE THERAPEUTICS INC Investor Conferences 8-K Filing 2024 - Annual Meeting of Stockholders Inhibikase Therapeutics, Inc. held its 2024 Annual Meeting of Stockholders, where proposals for electing a director, ratifying the appointment of an accounting firm, and approving an amendment to the company's equity incentive plan were approved, while a proposal to amend the company's certificate of incorporation was not adopted.Get access to all SEC 8-K filings of the INHIBIKASE THERAPEUTICS INC